The ACCESS study a Zelen randomised controlled trial of a treatment package including problem solving therapy compared to treatment as usual in people who present to hospital after self-harm: study protocol for a randomised controlled trial

被引:3
|
作者
Hatcher, Simon [1 ]
Sharon, Cynthia [1 ]
House, Allan [2 ]
Collings, Sunny [3 ]
Parag, Varsha [4 ]
Collins, Nicola [1 ]
机构
[1] Univ Auckland, Dept Psychol Med, Fac Med & Hlth Sci, Auckland 1, New Zealand
[2] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England
[3] Univ Otago, Social Psychiat & Populat Mental Hlth Res Unit, Wellington, New Zealand
[4] Univ Auckland, Clin Trials Res Unit, Sch Populat Hlth, Auckland 1, New Zealand
来源
TRIALS | 2011年 / 12卷
关键词
ATTEMPTED-SUICIDE; INTERVENTION; HOPELESSNESS; DEPRESSION; ATTEMPTERS; SERVICES; SCALE;
D O I
10.1186/1745-6215-12-135
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: People who present to hospital after intentionally harming themselves pose a common and important problem. Previous reviews of interventions have been inconclusive as existing trials have been under powered and done on unrepresentative populations. These reviews have however indicated that problem solving therapy and regular written communications after the self-harm attempt may be an effective treatment. This protocol describes a large pragmatic trial of a package of measures which include problem solving therapy, regular written communication, patient support, cultural assessment, improved access to primary care and a risk management strategy in people who present to hospital after self-harm using a novel design. Methods: We propose to use a double consent Zelen design where participants are randomised prior to giving consent to enrol a large representative cohort of patients. The main outcome will be hospital attendance following repetition of self-harm, in the 12 months after recruitment with secondary outcomes of self reported self-harm, hopelessness, anxiety, depression, quality of life, social function and hospital use at three months and one year. Discussion: A strength of the study is that it is a pragmatic trial which aims to recruit large numbers and does not exclude people if English is not their first language. A potential limitation is the analysis of the results which is complex and may underestimate any effect if a large number of people refuse their consent in the group randomised to problem solving therapy as they will effectively cross over to the treatment as usual group. However the primary analysis is a true intention to treat analysis of everyone randomised which includes both those who consent and do not consent to participate in the study. This provides information about how the intervention will work in practice in a representative population which is a major advance in this study compared to what has been done before.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol
    Gould, Rebecca L.
    Thompson, Benjamin J.
    Rawlinson, Charlotte
    Kumar, Pavithra
    White, David
    Serfaty, Marc A.
    Graham, Christopher D.
    McCracken, Lance M.
    Bursnall, Matt
    Bradburn, Mike
    Young, Tracey
    Howard, Robert J.
    Al-Chalabi, Ammar
    Goldstein, Laura H.
    Lawrence, Vanessa
    Cooper, Cindy
    Shaw, Pamela J.
    McDermott, Christopher J.
    BMC NEUROLOGY, 2022, 22 (01)
  • [32] Obsessive Compulsive Treatment Efficacy Trial (OCTET) comparing the clinical and cost effectiveness of self-managed therapies: study protocol for a randomised controlled trial
    Gellatly, Judith
    Bower, Peter
    McMillan, Dean
    Roberts, Christopher
    Byford, Sarah
    Bee, Penny
    Gilbody, Simon
    Arundel, Catherine
    Hardy, Gillian
    Barkham, Michael
    Reynolds, Shirley
    Gega, Lina
    Mottram, Patricia
    Lidbetter, Nicola
    Pedley, Rebecca
    Peckham, Emily
    Connell, Janice
    Molle, Jo
    O'Leary, Neil
    Lovell, Karina
    TRIALS, 2014, 15
  • [33] Clinical and cost-effectiveness of a personalised health promotion intervention enabling independence in older people with mild frailty ('HomeHealth') compared to treatment as usual: study protocol for a randomised controlled trial
    Frost, Rachael
    Avgerinou, Christina
    Goodman, Claire
    Clegg, Andrew
    Hopkins, Jane
    Gould, Rebecca L.
    Gardner, Benjamin
    Marston, Louise
    Hunter, Rachael
    Manthorpe, Jill
    Cooper, Claudia
    Skelton, Dawn A.
    Drennan, Vari M.
    Logan, Pip
    Walters, Kate
    BMC GERIATRICS, 2022, 22 (01)
  • [34] The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial
    Kingslake, Jonathan
    Dias, Rebecca
    Dawson, Gerard R.
    Simon, Judit
    Goodwin, Guy M.
    Harmer, Catherine J.
    Morriss, Richard
    Brown, Susan
    Guo, Boliang
    Dourish, Colin T.
    Ruhe, Henricus G.
    Lever, Anne G.
    Veltman, Dick J.
    van Schaik, Anneke
    Deckert, Juergen
    Reif, Andreas
    Staeblein, Michael
    Menke, Andreas
    Gorwood, Philip
    Voegeli, Geraldine
    Perez, Victor
    Browning, Michael
    TRIALS, 2017, 18
  • [35] Community occupational therapy for people with dementia and family carers (COTiD-UK) versus treatment as usual (Valuing Active Life in Dementia [VALID] programme): study protocol for a randomised controlled trial
    Wenborn, Jennifer
    Hynes, Sinead
    Moniz-Cook, Esme
    Mountain, Gail
    Poland, Fiona
    King, Michael
    Omar, Rumana
    Morris, Steven
    Vernooij-Dassen, Myrra
    Challis, David
    Michie, Susan
    Russell, Ian
    Sackley, Catherine
    Graff, Maud
    O'Keeffe, Aidan
    Crellin, Nadia
    Orrell, Martin
    TRIALS, 2016, 17
  • [36] Mindfulness-based cognitive therapy v. treatment as usual in people with bipolar disorder: A multicentre, randomised controlled trial
    Hanssen, Imke
    Huijbers, Marloes
    Regeer, Eline
    van Bennekom, Marc Lochmann
    Stevens, Anja
    van Dijk, Petra
    Boere, Elvira
    Havermans, Rob
    Hoenders, Rogier
    Kupka, Ralph
    Speckens, Anne E.
    PSYCHOLOGICAL MEDICINE, 2023, 53 (14) : 6678 - 6690
  • [37] Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
    Husain, Muhammad I.
    Chaudhry, Imran B.
    Rahman, Raza R.
    Hamirani, Munir M.
    Qurashi, Inti
    Khoso, Ameer B.
    Deakin, John F. W.
    Husain, Nusrat
    Young, Allan H.
    TRIALS, 2015, 16
  • [38] Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
    Muhammad I. Husain
    Imran B. Chaudhry
    Raza R. Rahman
    Munir M. Hamirani
    Inti Qurashi
    Ameer B. Khoso
    John FW Deakin
    Nusrat Husain
    Allan H. Young
    Trials, 16
  • [39] Youth Culturally adapted Manual Assisted Problem Solving Training (YCMAP) in Pakistani adolescent with a history of self-harm: protocol for multicentre clinical and cost-effectiveness randomised controlled trial
    Husain, Nusrat
    Tofique, Sehrish
    Chaudhry, Imran B.
    Kiran, Tayyeba
    Taylor, Peter
    Williams, Christopher
    Memon, Rakhshi
    Aggarwal, Shilpa
    Alvi, Mohsin Hassan
    Ananiadou, S.
    Ansari, Moin Ahmad
    Aseem, Saadia
    Beck, Andrew
    Alam, Sumira
    Colucci, Erminia
    Davidson, Kate
    Edwards, Sarah
    Emsley, Richard
    Green, Jonathan
    Gumber, Anil
    Hawton, Keith
    Jafri, Farhat
    Khaliq, Ayesha
    Mason, Thomas
    Mcreath, Ann
    Minhas, Ayesha
    Naeem, Farooq
    Naqvi, Haider Ali
    Noureen, Amna
    Panagioti, Maria
    Patel, Anita
    Poppleton, Aaron
    Shiri, Tinevimbo
    Simic, Mima
    Sultan, Sarwat
    Nizami, Asad Tamizuddin
    Zadeh, Zainab
    Zafar, Shehla Naeem
    Chaudhry, Nasim
    BMJ OPEN, 2022, 12 (05):
  • [40] Narrative Exposure Therapy versus treatment as usual in a sample of trauma survivors who live under ongoing threat of violence in Rio de Janeiro, Brazil: study protocol for a randomised controlled trial
    Fernanda Serpeloni
    Jeanine Arabella Narrog
    Simone Gonçalves de Assis
    Joviana Quintes Avanci
    Samuel Carleial
    Anke Koebach
    Trials, 22